Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 1606 AL 1620

Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?

Ritchie DL, Barria MA.

Biomolecules. 2021 Feb 2;11(2):207. doi: 10.3390/biom11020207.

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer's disease from subjective cognitive decline and other dementias

Cicognola C, Hansson O, Scheltens P, Kvartsberg H, Zetterberg H, Teunissen CE, Blennow K.

Alzheimers Res Ther. 2021 Feb 8;13(1):38. doi: 10.1186/s13195-020-00756-6.

Neuropeptides: Roles and Activities as Metal Chelators in Neurodegenerative Diseases

Ben-Shushan S, Miller Y.

J Phys Chem B. 2021 Mar 25;125(11):2796-2811. doi: 10.1021/acs.jpcb.0c11151. Epub 2021 Feb 11.

The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer's disease pathology: From antioxidant to epigenetic therapy

Griñán-Ferré C, Bellver-Sanchis A, Izquierdo V, Corpas R, Roig-Soriano J, Chillón M, Andres-Lacueva C, Somogyvári M, Sőti C, Sanfeliu C, Pallàs M.

Ageing Res Rev. 2021 May;67:101271. doi: 10.1016/j.arr.2021.101271. Epub 2021 Feb 8.

Electrochemical biosensors for biometal-protein interactions in neurodegenerative diseases

Li S, Kerman K.

Biosens Bioelectron. 2021 May 1;179:113035. doi: 10.1016/j.bios.2021.113035. Epub 2021 Jan 26.

Targeting impaired nutrient sensing with repurposed therapeutics to prevent or treat age-related cognitive decline and dementia: A systematic review

Kioussis B, Tuttle CSL, Heard DS, Kennedy BK, Lautenschlager NT, Maier AB.

Ageing Res Rev. 2021 May;67:101302. doi: 10.1016/j.arr.2021.101302. Epub 2021 Feb 17.

The Efficacy of Ketogenic Therapies in the Clinical Management of People with Neurodegenerative Disease: A Systematic Review

Dewsbury LS, Lim CK, Steiner GZ.

Adv Nutr. 2021 Jul 30;12(4):1571-1593. doi: 10.1093/advances/nmaa180.

Region-specific vulnerability in neurodegeneration: lessons from normal ageing

Pandya VA, Patani R.

Ageing Res Rev. 2021 May;67:101311. doi: 10.1016/j.arr.2021.101311. Epub 2021 Feb 24.

Contextual Processing and the Impacts of Aging and Neurodegeneration: A Scoping Review

Tran KH, McDonald AP, D'Arcy RCN, Song X.

Clin Interv Aging. 2021 Feb 24;16:345-361. doi: 10.2147/CIA.S287619. eCollection 2021.

A Scoping Review of Neuromodulation Techniques in Neurodegenerative Diseases: A Useful Tool for Clinical Practice?

Marson F, Lasaponara S, Cavallo M.

Medicina (Kaunas). 2021 Feb 27;57(3):215. doi: 10.3390/medicina57030215.

Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy

Nazam F, Shaikh S, Nazam N, Alshahrani AS, Hasan GM, Hassan MI.

Mol Cell Biochem. 2021 Jul;476(7):2739-2752. doi: 10.1007/s11010-021-04120-6. Epub 2021 Mar 9.

Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression

Krokidis MG, Exarchos TP, Vlamos P.

Math Biosci Eng. 2021 Feb 22;18(2):1813-1832. doi: 10.3934/mbe.2021094.

Genetic testing in dementia-A medical genetics perspective

Huq AJ, Sexton A, Lacaze P, Masters CL, Storey E, Velakoulis D, James PA, Winship IM.

Int J Geriatr Psychiatry. 2021 Aug;36(8):1158-1170. doi: 10.1002/gps.5535. Epub 2021 Mar 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias